Clinical Trial Update: Noninvasive Peripheral Nerve Stimulation for Medication-Refractory Primary RLS (The RESTFUL Study) [NA]

View source ↗

Summary

The RESTFUL study, sponsored by Noctrix Health, evaluated noninvasive peripheral nerve stimulation for medication-refractory primary Restless Legs Syndrome; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Restless Legs Syndrome

Drugs mentioned

• RESTFUL noninvasive peripheral nerve stimulation device

Snippet

Sponsor: Noctrix Health, Inc. | Conditions: Restless Legs Syndrome | NA | Status: COMPLETED | Results posted: 2024-09-19